Results for 'regulation'
Accelerated drug approvals in oncology: Pros and cons
Sep 13th • 4 mins read
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
Jun 20th • 28 mins read
The regulatory landscape of precision oncology laboratory medicine in the United States - Perspective on the past 5 years and considerations for future regulation
May 21st • 8 mins read
Oncology biosimilars: New developments and future directions
Nov 24th • 30 mins read
Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
May 8th • 5 mins read
Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Nov 9th • 6 mins read
Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
Jun 23rd • 18 mins read
Cancer drug development: The missing links
Apr 17th • 20 mins read
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Dec 12th • 7 mins read
AI-powered real-world evidence: Strategically enhancing value and access
Aug 21st • 5 mins read